These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30917691)

  • 1. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.
    Fritzen K; Basinska K; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Zakrzewska K; Schnell O
    J Diabetes Sci Technol; 2019 Nov; 13(6):1112-1122. PubMed ID: 30917691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.
    Fritzen K; Basinska K; Stautner C; Braun KF; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Hosny Y; Schnell O
    J Diabetes Sci Technol; 2020 Mar; 14(2):262-270. PubMed ID: 31387385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
    Schnell O; Erbach M
    J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System.
    Fritzen K; Gutschek B; Coucke B; Zakrzewska K; Hummel M; Schnell O
    J Diabetes Sci Technol; 2018 Sep; 12(5):1002-1006. PubMed ID: 29436251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.
    Schnell O; Erbach M; Wintergerst E
    J Diabetes Sci Technol; 2013 Jul; 7(4):904-12. PubMed ID: 23911172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
    Schiel R; Müller UA; Stein G
    Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective study.
    Kesavadev J; Shankar A; Pillai PB; Krishnan G; Jothydev S
    Diabetes Technol Ther; 2012 Sep; 14(9):772-6. PubMed ID: 22734662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
    Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
    Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of managing severe hypoglycaemia in three European countries.
    Hammer M; Lammert M; Mejías SM; Kern W; Frier BM
    J Med Econ; 2009; 12(4):281-90. PubMed ID: 20001570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.
    Palmer JL; Goodall G; Nielsen S; Kotchie RW; Valentine WJ; Palmer AJ; Roze S
    Curr Med Res Opin; 2008 May; 24(5):1417-28. PubMed ID: 18400145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of insulin initiation on resource utilization and direct costs of treatment over 12 months in patients with type 2 diabetes in Europe: results from INSTIGATE and TREAT observational studies.
    Brismar K; Benroubi M; Nicolay C; Schmitt H; Giaconia J; Reaney M
    J Med Econ; 2013 Aug; 16(8):1022-35. PubMed ID: 23738910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-monitoring of blood glucose in diabetes.
    Drug Ther Bull; 2007 Sep; 45(9):65-9. PubMed ID: 17894194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of treatment and complications of adult type 1 diabetes.
    Franciosi M; Lucisano G; Amoretti R; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Vitacolonna E; Nicolucci A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):606-11. PubMed ID: 22749531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.